Vitamin D supplementation and bone turnover in advanced heart failure: The EVITA trial
Osteoporosis International Dec 30, 2017
Zittermann A, et al. - Researchers undertook this investigation to determine the impact of a daily vitamin D3 dose of 4000 IU on bone turnover markers (BTMs) in patients with advanced heart failure (HF) and 25-hydroxyvitamin D (25OHD) concentrations < 75 nmol/L. No effect of a daily vitamin D3 dose of 4000 IU on BTMs was reported in this study. The observations pointed out that vitamin D supplementation will not lower bone turnover in male patients with heart failure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries